Market Cap | 4.11M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -88.57M | Forward P/E | -2.05 | EPS next Y | 97.40% | 50D Avg Chg | -30.00% |
Sales | 90k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -74.00% |
Dividend | N/A | Price/Book | 0.09 | EPS next 5Y | - | 52W High Chg | -94.00% |
Recommedations | 1.00 | Quick Ratio | 2.76 | Shares Outstanding | 6.46M | 52W Low Chg | 4.00% |
Insider Own | 36.85% | ROA | -47.89% | Shares Float | 4.22M | Beta | - |
Inst Own | 11.00% | ROE | -325.25% | Shares Shorted/Prior | 81.46K/78.69K | Price | 0.64 |
Gross Margin | 15.56% | Profit Margin | - | Avg. Volume | 261,880 | Target Price | 7.00 |
Oper. Margin | -30,760.00% | Earnings Date | Aug 14 | Volume | 32,452 | Change | -1.86% |
Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.